Results 81 to 90 of about 16,654,125 (262)

Does customer's climate risk disclosure affect supplier's cash holdings? Evidence from China's listed firms

open access: yesInternational Review of Economics & Finance
This study utilizes supply chain data from Chinese A-share listed companies to explore how customers' climate risk disclosures influence their suppliers' cash holdings. Our findings indicate that a 1% increase in customers' climate risk disclosures leads
Geng Chen, Yikai Han
doaj   +1 more source

From mice to humans—divergent strategies for intestinal homeostasis and regeneration

open access: yesFEBS Letters, EarlyView.
Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa   +2 more
wiley   +1 more source

Research on the Influence Mechanism of Digital Finance on the New Quality Productive Forces of Enterprises [PDF]

open access: yesSHS Web of Conferences
Digital finance and new quality productive forces (NQPFs) are hot issues in current research. Researchers have found that digital finance can effectively promote the development of NQPFs of enterprises. The purpose of this paper is to explore how digital
Chen Yuan
doaj   +1 more source

Risks to global biodiversity and Indigenous lands from China’s overseas development finance

open access: yesNature Ecology & Evolution, 2021
Hongbo Yang   +7 more
semanticscholar   +1 more source

Application of waqf for social and development finance

open access: yes, 2017
Purpose This paper aims to discuss the application of waqf (endowment) in the social finance sector for funding social and development projects and services. Design/methodology/approach The study is qualitative.
Salman Ahmed Shaikh   +2 more
semanticscholar   +1 more source

Ligand‐dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry

open access: yesFEBS Letters, EarlyView.
EGF and HRG induce distinct G1/S progression programs in ErbB2‐amplified BT474 breast cancer cells. Despite activating the potent ErbB2–ErbB3 heterodimer, HRG does not accelerate cell‐cycle entry. Instead, EGF promotes earlier restriction‐point passage via ERK–FOS signaling, whereas HRG activates the AKT–MYC axis, driving transcriptional heterogeneity ...
Ririn Rahmala Febri   +5 more
wiley   +1 more source

Trends in socioeconomic inequality in e-cigarette use among adolescents in South Korea

open access: yesTobacco Induced Diseases
Introduction The global rise in e-cigarette use among adolescents is alarming, with associated socioeconomic inequalities posing potential public health risks.
Gaoran Chen   +4 more
doaj   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy